Epizyme (EPZM) Tops Q1 EPS by 6c

Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($0.49), $0.06 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $210 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Movano (MOVE) Misses Q2 EPS by 195c